The Vancouver Consensus: Antiretroviral medicines, medical evidence, and political will

The Lancet

Volumn 386, Issue 9993, 2015, Pages 505-507

  Beyrer, Chris ^a,b   Birx, Deborah L ^c   Bekker, Linda Gail ^d   Barré Sinoussi, Françoise ^e   Cahn, Pedro ^f   Dybul, Mark R ^g   Eholié, Serge P ^h,i   Kavanagh, Matthew M ^j,k   Katabira, Elly T ^l   Lundgren, Jens D ^m   Mworeko, Lilian ⁿ   Pala, Marama ^o   Puttanakit, Thanyawee ^p   Ryan, Owen ^b   Sidibé, Michel ^b   Montaner, Julio S G ^q  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNAIDS   (Switzerland)

^c US President's Emergency Plan for AIDS Relief   (United States)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e INSTITUT PASTEUR   (France)

^f UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

^h UNIVERSITÉ FÉLIX HOUPHOUËT BOIGNY   (Côte d’Ivoire)

ⁱ INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE   (United States)

^j Health Global Access Project   (United States)

^k UNIVERSITY OF PENNSYLVANIA   (United States)

^l MAKERERE UNIVERSITY   (Uganda)

^m UNIVERSITY OF COPENHAGEN   (Denmark)

ⁿ International Community of Women Living with HIV East Africa   (Uganda)

^o International Indigenous Working Group on HIV and AIDS   (New Zealand)

^p CHULALONGKORN UNIVERSITY   (Thailand)

^q UNIVERSITY OF BRITISH COLUMBIA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT;

CANADA; CD4 LYMPHOCYTE COUNT; CONSENSUS; DEVELOPING COUNTRY; EVIDENCE BASED PRACTICE; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; INFECTION PREVENTION; NOTE; POLITICS; PRIORITY JOURNAL; STIGMA; HEALTH CARE DELIVERY; HEALTH PERSONNEL ATTITUDE; HIV INFECTIONS; TRANSMISSION;

ANTI-RETROVIRAL AGENTS; ATTITUDE OF HEALTH PERSONNEL; CONSENSUS; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS;

EID: 84938896200     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)61458-1     Document Type: Note

References (13)

1. C Beyrer, DL Birx, JSG Montaner et al. The Vancouver Consensus http://vancouverconsensus.org/ July, 2015 (accessed July 28, 2015).
2. The INSIGHT START Study Group Initiation of antiretroviral therapy in early asymptomatic HIV infection N Engl J Med 2015 10.1056/NEJMoa1506816 published online July 20.
3. The TEMPRANO ANRS 12136 Study Group A trial of early antiretrovirals and isoniazid preventive therapy in Africa N Engl J Med 2015 10.1056/NEJMoa1507198 published online July 20.
4. Cohen MS, Chen YQ, McCauley M et al. Final results of the HPTN 052 randomized controlled trial: antiretroviral therapy prevents HIV transmission. 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; Vancouver, Canada; July 19-22, 2015. MOAC0106LB.
5. Liu A, Cohen S, Vittinghoff E, Anderson P; Demo Project Study Group. Adherence, sexual behavior and HIV/STI incidence among men who have sex with men (MSM) and transgender women (TGW) in the US PrEP Demonstration (Demo) Project. 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; Vancouver, Canada; July 19-22, 2015. TUAC0202.
6. Grinsztejn B, Hoagland B, Veloso V et al. Pre-exposure prophylaxis (PrEP) uptake and associated factors among MSM and TGW in the PrEP Brasil demonstration project. 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; Vancouver, Canada; July 19-22, 2015. TUAC0205LB.
7. R Granich, S Gupta Global database of national HIV guidelines 2015 International Association of Providers of AIDS Care Washington, DC
8. WHO Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach 2013 World Health Organization Geneva
9. Mosquita F. Pre-exposure prophylaxis: the missing piece of combination prevention. 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; Vancouver, Canada; July 19-22, 2015. WEPL0101.
10. UNAIDS 90-90-90 - An ambitious treatment target to help end the AIDS epidemic 2014 Joint United Nations Programme on HIV/AIDS Geneva
11. V Jain, DM Byonanebye, G Amanyire et al. Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/μl in rural Uganda AIDS 28 2014 2241 2249
12. Hayes R, Ayles H, Beyers N, et al. Uptake of first year of a combination HIV prevention intervention including universal HIV testing and treatment across 4 communities in Zambia. 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; Vancouver, Canada; July 19-22, 2015. MOLBPE19.
13. UNAIDS The GAP report 2014 Joint United Nations Programme on HIV/AIDS Geneva http://www.unaids.org/en/resources/documents/2014/name,97466,en.asp (accessed July 25, 2015).